Research Funding
Altis Biosystems Awards New Research Funding to Armed Forces Radiobiology Research Institute
Altis Biosystems
PR-M02-22-09Feb 09, 2022
Research Funding
Altis Biosystems Announces New Research Funding Initiative
Altis Biosystems
PR-M09-21-03Sep 09, 2021
Tissue Models
Accurately Recapitulating Environmental Niches in In Vitro Models of the Intestine
Liz Boazak, Ph.D.
Altis Biosystems
PAO-03-21-CL-01Mar 11, 2021
Tissue Models
Developing a Robust In Vitro Intestinal Model for Preclinical Candidate Screening of GI Toxicity
Ron Laethem, Ph.D.
Altis Biosystems
PAO-02-21-CL-04Feb 18, 2021
Tissue Models
Recapitulating the Multifaceted Inflammatory Environment of the Intestine In Vitro
Bailey Zwarycz, Ph.D
Altis Biosystems
PAO-02-21-CL-01Feb 04, 2021
Tissue Models
The Power of RepliGut In Vitro Intestinal Stem Cell Models
Bailey Zwarycz, Ph.D
Altis Biosystems
PA1081Jan 26, 2021
Preclinical
Increasing the Efficiency of Drug Development with Preclinical Testing Using Human Intestinal Stem Cells
Ron Laethem, Ph.D.
Altis Biosystems
PAO-11-20-CL-01Dec 09, 2020
The Future of Healthcare
How Does Altis Biosystems Envision the Future of the Pharma/Biopharma Industry?
Altis Biosystems
PAP-Q4-20-RT2-015Dec 09, 2020
Gene Editing
Enhancing Human Gut Tissue Models through Gene Editing
Scott Magness, Ph.D.
Altis Biosystems
PAO-11-20-CL-03Nov 30, 2020
Microbiome
Evaluating Microbiome Therapies with Intestinal Cell Models
Scott Magness, Ph.D.
Altis Biosystems
PAO-10-20-CL-02Oct 22, 2020
Microphysiological Systems
Accelerating Drug Development with Microphysiological Systems (MPS)
Nancy Allbritton, Ph.D., M.D.
Altis Biosystems
PAP-Q3-20-CL-003Sep 29, 2020
Investment
Altis Biosystems Announces Completion of a $3.1 Million Seed Investment Led by VentureSouth
Altis Biosystems
PR-M08-20-NI-18Aug 11, 2020